These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 22010213)
1. Molecular determinants of retinoic acid sensitivity in pancreatic cancer. Gupta S; Pramanik D; Mukherjee R; Campbell NR; Elumalai S; de Wilde RF; Hong SM; Goggins MG; De Jesus-Acosta A; Laheru D; Maitra A Clin Cancer Res; 2012 Jan; 18(1):280-9. PubMed ID: 22010213 [TBL] [Abstract][Full Text] [Related]
2. CRABP2 and FABP5 expression levels in diseased and normal pancreas. Hughes CS; ChinAleong JA; Kocher HM Ann Diagn Pathol; 2020 Aug; 47():151557. PubMed ID: 32593808 [TBL] [Abstract][Full Text] [Related]
3. 4-Amino-2-trifluoromethyl-phenyl retinate inhibits proliferation, invasion, and migration of breast cancer cells by independently regulating CRABP2 and FABP5. Ju J; Wang N; Wang J; Wu F; Ge J; Chen F Drug Des Devel Ther; 2018; 12():997-1008. PubMed ID: 29731607 [TBL] [Abstract][Full Text] [Related]
4. Association of FABP5 expression with poor survival in triple-negative breast cancer: implication for retinoic acid therapy. Liu RZ; Graham K; Glubrecht DD; Germain DR; Mackey JR; Godbout R Am J Pathol; 2011 Mar; 178(3):997-1008. PubMed ID: 21356353 [TBL] [Abstract][Full Text] [Related]
5. Antitumor effects of all-trans retinoic acid and its synergism with gemcitabine are associated with downregulation of p21-activated kinases in pancreatic cancer. Wang K; Baldwin GS; Nikfarjam M; He H Am J Physiol Gastrointest Liver Physiol; 2019 May; 316(5):G632-G640. PubMed ID: 30844294 [TBL] [Abstract][Full Text] [Related]
7. Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer. Kocher HM; Basu B; Froeling FEM; Sarker D; Slater S; Carlin D; deSouza NM; De Paepe KN; Goulart MR; Hughes C; Imrali A; Roberts R; Pawula M; Houghton R; Lawrence C; Yogeswaran Y; Mousa K; Coetzee C; Sasieni P; Prendergast A; Propper DJ Nat Commun; 2020 Sep; 11(1):4841. PubMed ID: 32973176 [TBL] [Abstract][Full Text] [Related]
8. Analysis of CRABP2 and FABP5 genes in primary and recurrent pterygium tissues. Celik SD; Ates O Mol Biol Rep; 2020 Aug; 47(8):6105-6110. PubMed ID: 32780252 [TBL] [Abstract][Full Text] [Related]
9. Cellular Retinoic-Acid Binding Protein 2 in Solid Tumor. Jiao X; Liu R; Huang J; Lu L; Li Z; Xu L; Li E Curr Protein Pept Sci; 2020; 21(5):507-516. PubMed ID: 32013828 [TBL] [Abstract][Full Text] [Related]
10. Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model. Touma SE; Goldberg JS; Moench P; Guo X; Tickoo SK; Gudas LJ; Nanus DM Clin Cancer Res; 2005 May; 11(9):3558-66. PubMed ID: 15867260 [TBL] [Abstract][Full Text] [Related]
11. CRABP-II- and FABP5-independent all-trans retinoic acid resistance in COLO 16 human cutaneous squamous cancer cells. Chen NN; Li Y; Wu ML; Liu ZL; Fu YS; Kong QY; Chen XY; Li H; Liu J Exp Dermatol; 2012 Jan; 21(1):13-8. PubMed ID: 22082219 [TBL] [Abstract][Full Text] [Related]
12. Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal adenocarcinoma. Wong MH; Xue A; Julovi SM; Pavlakis N; Samra JS; Hugh TJ; Gill AJ; Peters L; Baxter RC; Smith RC Clin Cancer Res; 2014 Aug; 20(15):4047-58. PubMed ID: 24895459 [TBL] [Abstract][Full Text] [Related]
13. Effects of simvastatin on retinoic acid system in primary human endometrial stromal cells and in a chimeric model of human endometriosis. Sokalska A; Anderson M; Villanueva J; Ortega I; Bruner-Tran KL; Osteen KG; Duleba AJ J Clin Endocrinol Metab; 2013 Mar; 98(3):E463-71. PubMed ID: 23337719 [TBL] [Abstract][Full Text] [Related]
14. High FABP5 Versus CRABPII Expression Ratio in Recurrent Craniopharyngiomas: Implications for Future Treatment. Li Q; You C; Zhou L; Sima X; Liu Z; Liu H; Xu J World Neurosurg; 2016 Oct; 94():197-205. PubMed ID: 27418530 [TBL] [Abstract][Full Text] [Related]
15. CRABP2 regulates invasion and metastasis of breast cancer through hippo pathway dependent on ER status. Feng X; Zhang M; Wang B; Zhou C; Mu Y; Li J; Liu X; Wang Y; Song Z; Liu P J Exp Clin Cancer Res; 2019 Aug; 38(1):361. PubMed ID: 31419991 [TBL] [Abstract][Full Text] [Related]
16. CRABP1 and CRABP2 Protein Levels Correlate with Each Other but Do Not Correlate with Sensitivity of Breast Cancer Cells to Retinoic Acid. Enikeev AD; Komelkov AV; Axelrod ME; Galetsky SA; Kuzmichev SA; Tchevkina EM Biochemistry (Mosc); 2021 Feb; 86(2):217-229. PubMed ID: 33832420 [TBL] [Abstract][Full Text] [Related]
17. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer. Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172 [TBL] [Abstract][Full Text] [Related]
18. CRABP1 is associated with a poor prognosis in breast cancer: adding to the complexity of breast cancer cell response to retinoic acid. Liu RZ; Garcia E; Glubrecht DD; Poon HY; Mackey JR; Godbout R Mol Cancer; 2015 Jul; 14():129. PubMed ID: 26142905 [TBL] [Abstract][Full Text] [Related]
19. Uncovering Cellular retinoic acid-binding protein 2 as a potential target for rheumatoid arthritis synovial hyperplasia. Mosquera N; Rodriguez-Trillo A; Mera-Varela A; Gonzalez A; Conde C Sci Rep; 2018 Jun; 8(1):8731. PubMed ID: 29880835 [TBL] [Abstract][Full Text] [Related]
20. CRABP-II- and FABP5-independent responsiveness of human glioblastoma cells to all-trans retinoic acid. Xia SL; Wu ML; Li H; Wang JH; Chen NN; Chen XY; Kong QY; Sun Z; Liu J Oncotarget; 2015 Mar; 6(8):5889-902. PubMed ID: 25797252 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]